Correlation Between VaccibodyAs and Aditxt
Can any of the company-specific risk be diversified away by investing in both VaccibodyAs and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VaccibodyAs and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VaccibodyAs and Aditxt Inc, you can compare the effects of market volatilities on VaccibodyAs and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VaccibodyAs with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of VaccibodyAs and Aditxt.
Diversification Opportunities for VaccibodyAs and Aditxt
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between VaccibodyAs and Aditxt is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding VaccibodyAs and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and VaccibodyAs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VaccibodyAs are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of VaccibodyAs i.e., VaccibodyAs and Aditxt go up and down completely randomly.
Pair Corralation between VaccibodyAs and Aditxt
Given the investment horizon of 90 days VaccibodyAs is expected to generate 0.32 times more return on investment than Aditxt. However, VaccibodyAs is 3.08 times less risky than Aditxt. It trades about 0.03 of its potential returns per unit of risk. Aditxt Inc is currently generating about 0.0 per unit of risk. If you would invest 507.00 in VaccibodyAs on January 26, 2024 and sell it today you would lose (16.00) from holding VaccibodyAs or give up 3.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 76.57% |
Values | Daily Returns |
VaccibodyAs vs. Aditxt Inc
Performance |
Timeline |
VaccibodyAs |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aditxt Inc |
VaccibodyAs and Aditxt Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with VaccibodyAs and Aditxt
The main advantage of trading using opposite VaccibodyAs and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VaccibodyAs position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.VaccibodyAs vs. Molecular Partners AG | VaccibodyAs vs. MediciNova | VaccibodyAs vs. Anebulo Pharmaceuticals | VaccibodyAs vs. Champions Oncology |
Aditxt vs. Terns Pharmaceuticals | Aditxt vs. Amylyx Pharmaceuticals | Aditxt vs. Acumen Pharmaceuticals | Aditxt vs. Inozyme PharmaInc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |